
How has EoE and its treatments affected your life? Adult patients and their caregivers, share your experience:
Patient and carer experiences with medicines used to treat Eosinophilic Oesophagitis (EoE) in adults.
The medicine budesonide is now available as Jorveza, a tablet that dissolves on the tongue, this medication has been approved by the European Medical Agency (EMA) and is currently being evaluated for use as an NHS treatment for adults with Eosinophilic Oesophagitis (EoE).
As part of this evaluation process, the charities Guts UK and EOS Network have been asked to submit a report into how Eosinophilic Oesophagitis (EoE) affects patients and their families/caregivers quality of life. We would like to include your experiences on the advantages and disadvantages of current treatments to give the committee a good understanding.
If you are an adult Eosinophilic Oesophagitis (EoE) patient, or caregiver/family member of an adult with Eosinophilic Oesophagitis (EoE), please complete the following survey to help us with our report.
The deadline for completion of this survey is 22nd July 2020.
> Click here to take part in this important survey